These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2189589)

  • 1. Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice.
    Chiannilkulchai N; Ammoury N; Caillou B; Devissaguet JP; Couvreur P
    Cancer Chemother Pharmacol; 1990; 26(2):122-6. PubMed ID: 2189589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles.
    Verdun C; Brasseur F; Vranckx H; Couvreur P; Roland M
    Cancer Chemother Pharmacol; 1990; 26(1):13-8. PubMed ID: 2322986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin-loaded nanoparticles: increased efficiency in murine hepatic metastases.
    Chiannilkulchai N; Driouich Z; Benoit JP; Parodi AL; Couvreur P
    Sel Cancer Ther; 1989; 5(1):1-11. PubMed ID: 2756244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with doxorubicin-bound polyisohexylcyanoacrylate nanoparticles on murine alveolar echinococcosis of the liver.
    Liance M; Nemati F; Bories C; Couvreur P
    Int J Parasitol; 1993 May; 23(3):427-9. PubMed ID: 8359996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the role of macrophages on the cytotoxicity of doxorubicin and doxorubicin-loaded nanoparticles on M5076 cells in vitro.
    Soma CE; Dubernet C; Barratt G; Benita S; Couvreur P
    J Control Release; 2000 Aug; 68(2):283-9. PubMed ID: 10925136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
    Qi WW; Yu HY; Guo H; Lou J; Wang ZM; Liu P; Sapin-Minet A; Maincent P; Hong XC; Hu XM; Xiao YL
    Mol Pharm; 2015 Mar; 12(3):675-83. PubMed ID: 25584860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver metastases from colorectal cancer: drug delivery with liposome-encapsulated doxorubicin.
    Cay O; Kruskal JB; Nasser I; Thomas P; Clouse ME
    Radiology; 1997 Oct; 205(1):95-101. PubMed ID: 9314969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo study of Gal-OS self-assembled nanoparticles for liver-targeting delivery of doxorubicin.
    Guo H; Zhang D; Li T; Li C; Guo Y; Liu G; Hao L; Shen J; Qi L; Liu X; Luan J; Zhang Q
    J Pharm Sci; 2014 Mar; 103(3):987-93. PubMed ID: 24549734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes.
    Harasym TO; Cullis PR; Bally MB
    Cancer Chemother Pharmacol; 1997; 40(4):309-17. PubMed ID: 9225948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ distribution and antitumor activity of free and liposomal doxorubicin injected into the hepatic artery.
    Zou Y; Horikoshi I; Kasagi T; Gu X; Perez-Soler R
    Cancer Chemother Pharmacol; 1993; 31(4):313-8. PubMed ID: 8422696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nanoparticles of doxorubicin: colloidal vectors in the treatment of hepatic metastases in animals].
    Chiannilkulchai N; Driouich Z; Benoit JP; Parodi AL; Couvreur P
    Bull Cancer; 1989; 76(8):845-8. PubMed ID: 2620111
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhanced therapeutic effect against liver W256 carcinosarcoma with temperature-sensitive liposomal adriamycin administered into the hepatic artery.
    Zou Y; Yamagishi M; Horikoshi I; Ueno M; Gu X; Perez-Soler R
    Cancer Res; 1993 Jul; 53(13):3046-51. PubMed ID: 8319211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting behavior of hepatic artery injected temperature sensitive liposomal adriamycin on tumor-bearing rats.
    Zou YY; Ueno M; Yamagishi M; Horikoshi I; Yamashita I; Tazawa K; Gu XQ
    Sel Cancer Ther; 1990; 6(3):119-27. PubMed ID: 2281201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting beads for liver embolization: concentration of doxorubicin in tissue and in beads in a pig model.
    Namur J; Wassef M; Millot JM; Lewis AL; Manfait M; Laurent A
    J Vasc Interv Radiol; 2010 Feb; 21(2):259-67. PubMed ID: 20123210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic activity and tissue distribution of ME2303, a new anthracycline containing fluorine, and its metabolites in mice bearing hepatic metastases of Lewis lung carcinoma.
    Iigo M; Nishikata K; Nakajima Y; Hoshi A; Kadosawa H; Nakajima S
    Anticancer Drugs; 1990 Oct; 1(1):77-82. PubMed ID: 2131042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
    J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
    Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
    Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery.
    Tian Q; Zhang CN; Wang XH; Wang W; Huang W; Cha RT; Wang CH; Yuan Z; Liu M; Wan HY; Tang H
    Biomaterials; 2010 Jun; 31(17):4748-56. PubMed ID: 20303163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
    Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.